U.S. General Merchandise and Department Stores Stock News

PriceSmart, Inc. has already reported its third-quarter and nine-month results to May 31, 2026, with revenue rising to US$1,481.79 million and US$4,360.05 million respectively, alongside net income of US$39.69 million for the quarter and US$128.95 million for the nine-month period. The improvement in basic earnings per share from continuing operations, to US$1.28 for the quarter and US$4.19 for the nine months, highlights how recent performance compares with the prior year and may influence...

Oil and gas producers sit at the crossroads of several powerful forces right now, from a more uncertain Federal Reserve to renewed conflict in the Middle East and fresh inflation pressure linked to AI spending. That mix can shift earnings expectations, cash flows, and valuations quickly, especially for larger, financially healthy companies that are closely tied to energy prices. This article explains how those catalysts might matter for you as an investor and highlights 3 stocks from our Oil...

MSIG Europe Expands Use of Clearwater Platform Clearwater Analytics Holdings (CWAN) drew fresh attention after MSIG Europe selected its platform to modernize investment operations, unify data across the investment lifecycle, and address European regulatory requirements. This new mandate follows prior deployments at MSIG’s Asia office and other business units, giving Clearwater Analytics additional exposure to the insurance sector and a broader foothold in European markets. See our latest...

With Fed Chair Kevin Warsh signaling that interest rates may stay higher for longer, inflation still above the 2% target, and oil prices jumping after renewed tensions in the Strait of Hormuz, many investors are reassessing how reliable their income stocks really are. Dividend Aristocrats, with long records of raising payouts and a focus on financial discipline, can look appealing when volatility and inflation risks rise together. This article walks through 3 stocks from our Dividend...

Vestis (VSTS) is in focus after 29 workers represented by Teamsters Local 135 launched an unfair labor practice strike, citing alleged threats over protected concerted activity and seeking fair pay and improved benefits. See our latest analysis for Vestis. Vestis shares have been on a strong run, with a 30 day share price return of 12.96%, a 90 day share price return of 61.08%, and a year to date share price return of 126.44%. The 1 year total shareholder return of 148.75% suggests recent...

In recent days, Loop Capital downgraded Best Buy to Hold, citing leadership transitions involving the new CEO Jason Bonfig and the CFO, rising operational risks, and a wave of insider sales, including planned disposals from the Richard M. Schulze Revocable Trust dating back to founder-era shares. These governance and insider-selling concerns arrive as Best Buy’s more diversified electronics and services model contrasts with GameStop’s challenged core gaming business, reshaping how investors...

With markets on edge over energy shocks, inflation data and shifting rate expectations, many investors are looking for companies where insiders have meaningful skin in the game and where growth expectations remain optimistic. The Fast Growing Stocks With High Insider Ownership screener focuses on exactly that combination, highlighting businesses where management and analysts both see room for expansion and leaders are heavily invested alongside you. This article introduces three stocks from...

Keurig Dr Pepper recently reported strong growth in its U.S. Refreshment Beverages segment, highlighted by brands such as Dr Pepper and GHOST energy, while outlining a plan to split into two pure-play companies targeting about US$400 million in cost savings despite carrying approximately US$25.90 billion of debt. An interesting angle is that Barclays has called out Keurig Dr Pepper as potentially materially undervalued, with the proposed company split and the push to grow GHOST’s energy...

BeOne Medicines Ltd. recently reported positive topline results from its Phase 3 MANGROVE trial, where BRUKINSA (zanubrutinib) plus rituximab significantly improved progression-free survival versus bendamustine plus rituximab in previously untreated mantle cell lymphoma. This is the first global Phase 3 study to show a chemotherapy-free, rituximab maintenance-free regimen can match or exceed standard chemoimmunotherapy, potentially sparing patients around two years of infusion treatment...

American Financial Group, NYSE:AFG, is drawing attention for slower growth in net premiums earned relative to insurance peers. Earnings per share growth has been modest, while book value per share has declined compared with other insurers. These trends are prompting closer scrutiny of the company’s fundamentals and positioning within the insurance sector. American Financial Group, NYSE:AFG, is coming under closer review as recent data shows slower growth in key operating metrics than many...

ScanSource, Inc. recently announced an expanded partnership with HPE that now includes HPE Juniper Networking, broadening its networking, cybersecurity and AI-native enterprise solutions for channel partners and end users. A key feature of the announcement is the use of ScanSource Launch Point to accelerate HPE’s go-to-market efforts with tailored channel programs and new routes to market. We’ll now examine how this deeper HPE relationship, particularly the Launch Point go-to-market support,...

Rubrik stock has climbed about 23% over the past month. However, the latest valuation checks suggest it no longer stands out as a clear bargain, with the Discounted Cash Flow (DCF) intrinsic value estimate sitting close to, rather than far from, the current share price. Rubrik's roughly 23% gain in the past month highlights strong recent momentum that may already reflect a lot of optimism in the price. Recent announcements around AI driven security offerings and a sizeable UK investment can...

Insight Holdings Group has significantly reduced its stake in Hinge Health (NYSE:HNGE) after a period of revenue growth and improved guidance. The move follows reported efficiency gains from AI automation across Hinge Health's operations. The share sale comes with Hinge Health trading at a current share price of $90.0. Hinge Health sits in the spotlight as one of the more closely watched digital health stocks, with the share price at $90.0 and returns of 37.7% over the past 30 days and...

Earlier this week, PTC Therapeutics reported strong Q1 2026 earnings that surpassed analyst expectations, alongside insider stock sales executed under pre-arranged Rule 10b5-1 plans by director Mary L. Smith and Chief Technical Ops Officer Neil Gregory Almstead at around US$90 per share. While the insider transactions were planned in advance, analysts highlighted improved operations and the outlook for key rare disease therapy Sephience as central to the refreshed sentiment around the...

Insulet (NasdaqGS:PODD) has announced a global partnership with Calm to introduce mental health and mindfulness support tailored for people with diabetes and their caregivers. The collaboration creates a first-of-its-kind MedTech and mental health content collection integrated around diabetes care. The program is expected to roll out globally, supported by high-profile advocates from the diabetes community. Insulet, trading at $162.06, is widely recognized for its insulin delivery...

Centene (CNC) is back in focus after portfolio managers highlighted the stock’s strong reaction to better-than-expected quarterly results, pointing to stabilizing medical cost trends and management expense efforts as key drivers of shifting investor expectations. See our latest analysis for Centene. At a share price of $68.29, Centene’s recent momentum is clear, with a 90 day share price return of 83.28% and a 1 year total shareholder return of 122.88% reflecting how quickly sentiment has...

EquipmentShare.com (EQPT) has drawn fresh investor attention after raising its 2026 revenue outlook to a range of $5,254 million to $5,682 million and unveiling a new $500 million share repurchase program. See our latest analysis for EquipmentShare.com. Despite the raised 2026 revenue guidance and the new buyback authorization, EquipmentShare.com’s 1 day share price return declined 9.79%, contributing to a year to date share price return that is down 48.33% and signaling fading momentum in...

Blue Owl Capital’s share price has fallen 48.2% over the past year, yet the stock still screens as expensive on broad valuation checks, which raises a clear question about how much downside risk the current valuation still carries. Over the most recent 1 year window, Blue Owl Capital is down 48.2%, which means recent shareholders have worn a heavy drawdown that is front of mind when thinking about valuation risk. While acquisitions in healthcare real estate and digital infrastructure can...

Inflation is getting pulled in different directions right now, with energy swings, higher services costs, tech demand, and war driven spending all feeding into the same story. That mix can be uncomfortable for markets, but it can also create clear winners and losers as pricing power, cost control, and business models are put to the test. This article looks at 3 service sector stocks from our screener that appear closely tied to these trends and explains how the recent news could affect them...

Tootsie Roll Industries (TR) has drawn investor interest after recent share performance data showed the stock down about 1% over the past week, around 2% over the month, and roughly 12% over the past three months. See our latest analysis for Tootsie Roll Industries. Set against its longer history, Tootsie Roll Industries' recent share price softness contrasts with a positive year to date share price return of 10.59% and a 1 year total shareholder return of 10.96%. This suggests recent...

Nucor’s share price has delivered a strong 178.7% total return over the past 5 years, while its current valuation signals indicate that the stock still screens as undervalued on both intrinsic value estimates and market multiples. A 178.7% return over 5 years suggests Nucor has already rewarded patient shareholders. Any further potential upside now matters more for new investors weighing entry price against risk. Expectations for Nucor’s future cash generation can support the current...

Kimberly-Clark stock has slipped about 9.3% over the past year, yet an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach indicates the shares may trade at a meaningful discount to that assessment of fair value. With recent headlines on the Arbex joint venture, a large Kenvue acquisition and renewed interest from institutional investors, the key tension is whether the current price reflects these changes or still leaves upside relative to the intrinsic value...

Cooling US inflation at 3.5% in June, a sharp jump in oil prices and a cautious Federal Reserve under Kevin Warsh have put big bank stocks back in focus. Higher energy costs could keep inflation pressure alive, while interest rate policy remains a key swing factor for funding costs, loan demand and margins across large US banks. This article looks at three stocks from a US Bank Stocks screener that stand out for their financial strength and market presence, and explains how exposure to these...

Global Payments stock has lagged badly over the past five years while still screening as expensive on broad valuation checks, which sits awkwardly against recent analyst optimism that highlights it as an attractive opportunity. The share price is down about 57% over five years, so long term holders have taken a heavy hit that puts extra pressure on today’s valuation. Recent analyst commentary points to potential upside if growth in payments volumes and travel related activity materializes...